Proxy Votes Now

Home › Upcoming votes › Celularity Inc

Celularity Inc Annual Meeting December 30, 2026: What's on the Ballot

Say on paySignificant dissent last year

Prior-year votes at Celularity Inc → 2025-2026 season, in the search

The deadline as the proxy statement states it: “Votes submitted by telephone must be received by 11:59 p.m. Eastern Time on December 29, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.

Read the proxy statement on EDGAR

Proxy summary

Summary, checked against the proxy statement. Each point is backed by a passage of the filing, shown under the point; figures under “Last year’s votes” come from the company’s Form 8-K. Read the proxy statement before relying on it.

Annual meeting: election of one Class II director, auditor ratification, say-on-pay, say-on-pay frequency, an equity plan share increase and a financing-related share issuance.

Key points

What changed from last year

Last year’s votes

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in Celularity Inc’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.

#ItemProposed byBoard recommendsLast year (same kind of item)
1 Election of one Class II director (Steven N. Gordon, Esq.)
Director election
Board For 3 nominees; support 31% to 35%
2 Ratification of the appointment of EisnerAmper LLP for fiscal 2026
Auditor
Board For 99.7% support
3 Advisory vote to approve executive compensation
Say on pay
Board For —
4 Advisory vote on the frequency of future advisory votes on executive compensation
Say-on-pay frequency
Board 3 years —
5 Amendment to the 2021 Equity Incentive Plan to add 3,500,000 shares Board For —
6 Approval under Nasdaq Listing Rule 5635 of share issuance upon conversion of notes and exercise of warrants under the September 23, 2026 Securities Purchase Agreement Board For —

Last year’s official results

From Celularity Inc’s Form 8-K, filed December 19, 2025, for the meeting held December 19, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
Elect Director: Peter Diamandis, M.D.32%—
Elect Director: Diane Parks31%—
Elect Director: Geoffrey Ling, M.D.35%—
2. The appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31,99.7%Approved
3. The amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of common stock reserved and available for awa83%Not approved

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.